Vasodilators in Chronic Heart Failure (eBook, PDF)
Redaktion: Just, H.; Bussmann, W. -D.
73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
37 °P sammeln
73,95 €
Als Download kaufen
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
37 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
37 °P sammeln
Vasodilators in Chronic Heart Failure (eBook, PDF)
Redaktion: Just, H.; Bussmann, W. -D.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 26.47MB
Andere Kunden interessierten sich auch für
- Michael BöhmChronic Heart Failure (eBook, PDF)73,95 €
- Current Topics in Coronary Research (eBook, PDF)73,95 €
- Myocarditis Cardiomyopathy (eBook, PDF)73,95 €
- Pawel Petkow-DimitrowCoronary flow reserve - measurement and application: Focus on transthoracic Doppler echocardiography (eBook, PDF)73,95 €
- Angiocardiography (eBook, PDF)40,95 €
- Coronary Artery Surgery (eBook, PDF)73,95 €
- Congestive Heart Failure (eBook, PDF)113,95 €
-
-
-
Produktdetails
- Verlag: Springer Berlin Heidelberg
- Seitenzahl: 236
- Erscheinungstermin: 6. Dezember 2012
- Englisch
- ISBN-13: 9783642686054
- Artikelnr.: 53103509
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
I. Physiology.- Vasoconstrictor Mechanisms and the Effects of Nitrates.- Functional and Metabolic Consequences of Chronic Alterations in Preload and Afterload in the Hypertrophied and Dilated Heart.- The Sympathetic Nervous System in Chronic Heart Failure and Its Response to Vasodilator Therapy.- Regulation of Renal Hemodynamics in Congestive Heart Failure.- The Renin-Angiotensin-Aldosterone System in Congestive Heart Failure.- Endogenous Catecholamines Under Chronic Vasodilator Treatment.- Effects of Hydralazine and Isosorbide Dinitrate on Vasoconstrictor Mechanisms in Patients with Heart Failure.- II. Pharmacology.- Cellular Mechanism of Action of Directly Acting Vasodilator Drugs.- Pharmacokinetics of Nitrates.- Isosorbide Dinitrate: Pharmacokinetics After Intravenous Administration.- Prazosin and ?-Blocking Agents.- III. Clinical Experience.- Promises and Disappointments of Vasodilator Treatment of Chronic Heart Failure.- Nitrates in Chronic Heart Failure.- The Long-Term Effects of Dihydralazine and Hydralazine on Intractable Cardiac Failure.- The Use for Hydralazine in Chronic Cardiac Failure: Results and Unanswered Questions.- Prazosin Therapy in Severe Chronic Congestive Heart Failure.- Early Experience with Captopril in Congestive Heart Failure.- Acute Effect of Nifedipine on Left Ventricular Performance at Rest and During Exercise in Patients with Left Ventricular Dysfunction.- Treatment of Congestive Heart Failure with Dipyridamole.- Therapeutic Agents with Combined Inotropic and Vasodilating Properties.- Hemodynamic Effects of Combined Inotropic and Vasodilator Drugs in Severe Congestive Heart Failure: Hydralazine and Prenalterol.- AR-L 115 BS, a Substance with Inotropic and Vasodilating Effects.- Efficacy of AR-L 115 BS on Hemodynamics, Contractility, andMyocardial Oxygen Consumption in Man.- Treatment of Cardiac Failure with AR-L 115 BS.- IV. Conception and Planning of Future Studies.- Can Vasodilator Treatment Improve Life Expectancy and Physical Performance Heart Failure?.- Vasodilators in Chronic Heart Failure: Problems of Design and Analysis of Controlled Clinical Trials.
I. Physiology.- Vasoconstrictor Mechanisms and the Effects of Nitrates.- Functional and Metabolic Consequences of Chronic Alterations in Preload and Afterload in the Hypertrophied and Dilated Heart.- The Sympathetic Nervous System in Chronic Heart Failure and Its Response to Vasodilator Therapy.- Regulation of Renal Hemodynamics in Congestive Heart Failure.- The Renin-Angiotensin-Aldosterone System in Congestive Heart Failure.- Endogenous Catecholamines Under Chronic Vasodilator Treatment.- Effects of Hydralazine and Isosorbide Dinitrate on Vasoconstrictor Mechanisms in Patients with Heart Failure.- II. Pharmacology.- Cellular Mechanism of Action of Directly Acting Vasodilator Drugs.- Pharmacokinetics of Nitrates.- Isosorbide Dinitrate: Pharmacokinetics After Intravenous Administration.- Prazosin and ?-Blocking Agents.- III. Clinical Experience.- Promises and Disappointments of Vasodilator Treatment of Chronic Heart Failure.- Nitrates in Chronic Heart Failure.- The Long-Term Effects of Dihydralazine and Hydralazine on Intractable Cardiac Failure.- The Use for Hydralazine in Chronic Cardiac Failure: Results and Unanswered Questions.- Prazosin Therapy in Severe Chronic Congestive Heart Failure.- Early Experience with Captopril in Congestive Heart Failure.- Acute Effect of Nifedipine on Left Ventricular Performance at Rest and During Exercise in Patients with Left Ventricular Dysfunction.- Treatment of Congestive Heart Failure with Dipyridamole.- Therapeutic Agents with Combined Inotropic and Vasodilating Properties.- Hemodynamic Effects of Combined Inotropic and Vasodilator Drugs in Severe Congestive Heart Failure: Hydralazine and Prenalterol.- AR-L 115 BS, a Substance with Inotropic and Vasodilating Effects.- Efficacy of AR-L 115 BS on Hemodynamics, Contractility, andMyocardial Oxygen Consumption in Man.- Treatment of Cardiac Failure with AR-L 115 BS.- IV. Conception and Planning of Future Studies.- Can Vasodilator Treatment Improve Life Expectancy and Physical Performance Heart Failure?.- Vasodilators in Chronic Heart Failure: Problems of Design and Analysis of Controlled Clinical Trials.